Decomit® (Beclomethasone Dipropionate) 50mg Nasal Spray BP (100ml)

Indications of Decomit Nasal Spray

Beclometasone 50, 100 & 250 HFA Inhaler is shown within the prophylactic administration of mellow, direct, or extreme asthma in grown-ups or children. Beclometasone dipropionate given by inward breath offers preventative treatment for asthma. It provides effective anti-inflammatory activity within the lungs with a lower rate and seriousness of antagonistic impacts than those watched when corticosteroids are managed systemically. Mild asthma: Patients requiring symptomatic bronchodilator asthma medicine on a normal basis. Moderate asthma: Patients with unsteady or declining asthma in spite of prophylactic treatment or bronchodilator alone. Severe asthma: Patients with extreme incessant asthma and those who are subordinate on systemic corticosteroids for satisfactory control of indications. Numerous patients who are subordinate on systemic corticosteroids for satisfactory control of indications may be able to decrease altogether, or kill, their prerequisite for verbal corticosteroids when they are exchanged to tall measurements